Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) – Time For Strategy Change?

Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP) currently has a daily average trading volume of 1.75M but it saw 1891183 shares traded in last market. With a market cap of 223.66M USD, the company’s current market price of $0.87 came falling about -5.07 while comparing to the previous closing price of $0.92. In past 52 weeks, the […]